<i>Moraxella catarrhalis</i> adhesin UspA1-derived recombinant fragment rD-7 induces monocyte differentiation to CD14+CD206+ phenotype by Xie, Qi et al.
                          Xie, Q., Brackenbury, L., Hill, D., Williams, N., Qu, X., & Virji, M. (2014).
Moraxella catarrhalis adhesin UspA1-derived recombinant fragment rD-7
induces monocyte differentiation to CD14+CD206+ phenotype. PLoS ONE,
9(3), [e90999]. https://doi.org/10.1371/journal.pone.0090999
Publisher's PDF, also known as Version of record
License (if available):
CC BY
Link to published version (if available):
10.1371/journal.pone.0090999
Link to publication record in Explore Bristol Research
PDF-document
This is the final published version of the article (version of record). It first appeared online via Public Library of
Science at http://dx.doi.org/10.1371/journal.pone.0090999. Please refer to any applicable terms of use of the
publisher.
University of Bristol - Explore Bristol Research
General rights
This document is made available in accordance with publisher policies. Please cite only the published
version using the reference above. Full terms of use are available:
http://www.bristol.ac.uk/pure/about/ebr-terms
Moraxella catarrhalis Adhesin UspA1-derived
Recombinant Fragment rD-7 Induces Monocyte
Differentiation to CD14+CD206+ Phenotype
Qi Xie1, Louise S. Brackenbury2¤, Darryl J. Hill2, Neil A. Williams2*, Xun Qu1*, Mumtaz Virji2
1 Institute of Basic Medical Sciences, Qilu Hospital, Shandong University, Jinan, Shandong, P.R. China, 2 School of Cellular and Molecular Medicine, University of Bristol,
Bristol, United Kingdom
Abstract
Circulating monocytes in the bloodstream typically migrate to other tissues and differentiate into tissue resident
macrophages, the process being determined by the constituents of the microenvironments encountered. These may
include microbes and their products. In this study, we investigated whether Moraxella catarrhalis Ubiquitous Surface Protein
A1 (UspA1), known to bind to a widely expressed human cell surface receptor CEACAM1, influences monocyte
differentiation as receptor engagement has been shown to have profound effects on monocytes. We used the recombinant
molecules corresponding to the regions of UspA1 which either bind (rD-7; UspA1527–665) or do not bind (r6–8; UspA1659–863)
to CEACAM1 and investigated their effects on CD206, CD80 and CD86 expression on freshly isolated human CD14+
monocytes from peripheral blood mononuclear cells (PBMC). Exposure to rD-7, but not r6–8, biased monocyte
differentiation towards a CD14+CD206+ phenotype, with reduced CD80 expression. Monocytes treated with rD-7 also
secreted high levels of IL-1ra and chemokine IL-8 but not IL-10 or IL-12p70. The effects of rD-7 were independent of any
residual endotoxin. Unexpectedly, these effects of rD-7 were also independent of its ability to bind to CEACAM1, as
monocyte pre-treatment with the anti-CEACAM antibody A0115 known to inhibit rD-7 binding to the receptor, did not
affect rD-7-driven differentiation. Further, another control protein rD-7/D (a mutant form of rD-7, known not to bind to
CEACAMs), also behaved as the parent molecule. Our data suggest that specific regions of M. catarrhalis adhesin UspA1 may
modulate inflammation during infection through a yet unknown receptor on monocytes.
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Introduction
Monocytes and macrophages are both indispensable effector
cells critical in regulation of inflammation and in non-specific
innate immune responses, the first line of defence against invading
bacteria [1]. They also regulate adaptive immunity in a cell-cell
contact dependent manner or with secreted pro-inflammatory or
anti-inflammatory cytokines and chemokines [2].
Monocytes are the circulating precursors of tissue macrophages
and dendritic cells [3,4], and macrophage colony-stimulating
factor (M-CSF) is a potent monocyte/macrophage differentiation
factor [5]. During such differentiation, signals initiated by different
cytokines and specific surface receptors modify the process
generating either classically activated M1 macrophages or
alternatively activated M2 macrophages, which exhibit significant
differences in receptor, cytokine and chemokine expression, and
effector function. M1 macrophages are responsive to type 1
inflammatory cytokines as well as microbial products, whilst M2
macrophages can be induced by IL-4, IL-13, IL-1, IL-10 or
hormones [6]. Certain studies have suggested that pathogens, for
example Yersinia sp., may have adapted mechanisms to alter the
differentiation of monocytes via the expression of different
virulence factors [7,8]. M2 macrophages are characterized by
their expression of specific membrane and chemokine receptors,
such as mannose receptor (CD206), CD163, CXCR1, CXCR2,
CCR2 and also by their secretion of several cytokines and
chemokines, including IL-10, IL-1 receptor antagonist (IL-1ra),
CCL17, CCL18, and CCL22 [9,10]. CD206 is a transmembrane
C-type lectin primarily expressed on the surface of macrophages
and dendritic cells. It plays an important role in the innate
immune response, recognising pathogens through mannose
residues on their surfaces and mediating endocytosis and
phagocytosis [11]. CD80 (B7-1) and CD86 (B7-2) belong to the
B7 family of molecules and are expressed on antigen-presenting
cells which provide co-stimulatory signals for T cell activation and
survival [12]. Monocyte differentiation can also be regulated by
immunoglobulin superfamily receptors [13] including members of
the carcinoembryonic antigen (CEA) family.
Among the members of the CEA family, the CEA-related cell
adhesion molecule 1 (CEACAM1), also known as CD66a, is
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expressed on several types of cell including human granulocytes
and lymphocytes, endothelia, epithelia, extravillous trophoblasts
and some tumour cells. It serves as a sophisticated signalling
molecule which participates in regulating a variety of cellular
activities [14,15,16,17,18,19,20,21,22,23]. A vital role for CEA-
CAM1, the only member of the CEA family found on monocytes
[24,25], in the survival and function of monocytes has been
suggested; and CEACAM1-dependent regulation of primary
CD14+ monocyte survival and control of angiogenesis in a murine
inflammation model has also been reported [16,24]. In addition,
on a number of human cells, CEACAM1 is targeted by pathogens
such as Neisseria meningitidis, Neisseria gonorrhoeae [26], Haemophilus
influenzae [27], and Moraxella catarrhalis [28,29] via one or more
adhesins on their surface to alter the target cell function. Whether
such bacterial CEACAM-binding proteins can induce monocyte
differentiation in a receptor-dependent manner remains to be
shown.
Previous studies have identified a number of bacterial virulence-
associated adhesins such as the Opa proteins of Neisseriae [26], the
protein P5 of H. influenzae [27]and the UspA1 protein of M.
catarrhalis [28] that can specifically bind to the N-terminal domain
of CEACAM1. Furthermore, it has been reported that UspA1
protein of M. catarrhalis induces CEACAM1-dependent apoptosis
in alveolar epithelial cells and that this might contribute to the
pathogenesis of chronic obstructive pulmonary disease (COPD)
[30]. In addition, UspA1 also helps M. catarrhalis evade host
immunity through inhibiting both the alternative and classical
pathways of the complement system [31]. It has also been reported
that M. catarrhalis infected alveolar epithelium induced monocyte
recruitment [32], but little is known about the potential effects of
M. catarrhalis on the recruited monocyte differentiation after M.
catarrhalis infection. While monocytes may encounter multiple
stimulants presented on the bacterial surface (such as UspA1,
LPS), engagement of UspA1 with CEACAM1 has been reported
to be involved in the regulation not only of epithelial function (as
described above) but also of T cell function upon CEACAM-1
cross-linking [33]. Therefore, in this study, we focused on
addressing the potential effects of the CEACAM1 ligand UspA1
(and in particular the recombinant UspA1 fragment rD-7 that
binds to CEACAM1 [34,35]) on monocyte function. It is also
noteworthy that UspA1 has been deemed a potential vaccine
antigen to combat M. catarrhalis infections [34,36,37,38] and as
such it may be administered in its purified form either as a whole
molecule or as the rD-7 fragment. This might induce bactericidal
antibodies and/or inhibit bacterial colonization by binding to
epithelial CEACAMs [34]; however, these components may also
affect immune function on encountering CEACAMs on immune
cells. A fuller knowledge of how such M. catarrhalis components
affect the human immune response is therefore of particular
interest.
In addition to the recombinant molecules such as rD-7
corresponding to the CEACAM1-binding region of UspA1, we
have generated a control molecule r6–8 (based on a sequence of
UspA1 distinct from its receptor-binding sequence) and rD-7/D (a
mutant form of rD-7 with diminished ability to bind to
CEACAM1) [34,35]. Using these tools, we have investigated their
effects on differentiation of and cytokine secretion by human
myeloid-derived CD14+ monocytes.
Materials and Methods
Ethics Statement
Buffy Coats were obtained from healthy human volunteers
(National Blood Service, Bristol, UK; Shandong Blood Center,
Jinan, China) and written approval was obtained in each case. The
collection and use of blood and the research described complies
with the relevant guidelines and institutional practices (University
of Bristol Hospital Trust Local Research Ethical Committee
E4388) and also complies with relevant guidelines and institutional
practices from the Ethics Committees of Qilu Hospital of
Shandong University. Our study was specially approved by
University of Bristol Hospital Trust Local Research Ethical
Committee and the Ethics Committees of Qilu Hospital of
Shandong University (No.1179).
Antibodies, Cytokines, and Reagents used are Listed
Below
Rabbit anti-human Carcinoembryonic Antigen polyclonal
antibody (Ab) (Dako, Denmark Ab A0115); rabbit IgG control
(Vector, CA, USA); PE-conjugated anti-CEACAM1 monoclonal
antibody (mAb) (R and D Systems MAb2244); FITC-conjugated
mouse anti-human CD14 mAb, human FcR Blocking Reagent,
CD14+/CD15+ Microbeads and LS columns (Miltenyi biotec,
Germany); PE-conjugated mouse anti-human CD86 mAb and
PE-Cy7-conjugated mouse anti-human CD80 mAb (Biolegend,
CA, USA); PE-conjugated mouse anti-human CD206 mAb and
FITC-conjugated mouse anti-human CD15 mAb (Becton Dick-
inson, CA, USA); PE-conjugated goat anti-rabbit IgG antibody,
endotoxin-free water and Histopaque-1077 (Sigma, USA); fixable
Vital dye eFluor 780 (ebioscience, CA, USA); LPS-EK Ultrapure
(Invivogen, CA, USA); Ni-NTA agarose and polypropylene
column (QIAGEN); Pierce BCA Protein Assay Kit and Pierce
LAL Chromogenic Endotoxin Quantitation Kit (Thermo Scien-
tific); Proteome Profiler kits (R&D systems, UK). Antiserum to
recombinant rD-7 was raised in mice and has been described
previously [29].
Production and Identification of Recombinant rD-7, rD-7/
D and r6–8 Proteins
The recombinant UspA1 fragment rD-7 represents amino acids
527–665 of UspA1. The protein rD-7/D corresponds to the same
region of UspA1 (527–665) but with two point mutations
introduced by site directed mutagenesis (M568A and A588Q) of
full length UspA1. The recombinant protein r6–8 corresponds to
amino acids 659–863 of UspA1. Unlike rD-7, neither r6–8 nor rD-
7/D binds to CEACAM1. All three proteins were produced using
the pQE30 expression system (Qiagen) and have been described
previously [35]. Purified proteins were detected using an anti-His-
tag antibody and in the case of rD-7, also a soluble CEACAM1-Fc
construct [34] by western blotting (Fig. S1). The endotoxin levels
in all purified proteins were less than 1.0 EU/mg as determined by
Limulus Amoebocyte Lysate method.
Western Blot
The concentrations of rD-7 and rD-7/D were detected by BCA
Protein Assay Kit (Pierce) and the samples were heated for 5 min
at 100uC before loading 1 mg protein per well from each sample
on to a 12.5% gel. After separation by electrophoresis, the bands
of the expected size (17 kDa) were observed in Coomassie Blue
stained gels. And proteins were transferred to a nitrocellulose
membrane (Millipore) and the bands of expected size (17 kDa)
were observed in Western blots detected with anti-His tag
antibody (Novagen) and CEACAM1-Fc construct described
previously [39]. rD-7 and rD-7/D were detected with anti-His
tag antibody followed by anti-mouse IgG secondary antibody
conjugated to alkaline phosphatase (Sigma). CEACAM1-Fc bound
to rD-7 but not rD-7/D. Receptor binding was detected using an
UspA1 Induces CD14+CD206+ Monocyte Differentiation
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anti-human-Fc antibody conjugated to alkaline phosphatase. In
the case of both anti-His tag and receptor overlay, alkaline
phosphatase conjugates binding was detected by the addition of
nitroblue tetrazolium and 5-bromo-4-chloro-3-indoyl phosphate
as substrates (Sigma).
Digestion of rD-7 and rD-7/D
Samples of the purified recombinant molecules were digested
using 200 mg/ml Proteinase K (PK) at 37uC for 3 h and the
digested samples heated at 95uC for 1 h to inactive the enzyme.
The absence of intact proteins in the relevant samples was
confirmed using SDS-PAGE.
Isolation of Peripheral Blood Cells
PBMC were isolated from healthy human peripheral blood
derived buffy coats using Histopaque-1077. CD14+ monocytes or
CD15+ cells (human eosinophils and neutrophils) were then
separated by magnetic cell sorting using human CD14 and CD15
MicroBeads (Miltenyi Biotech) according to the manufacturer’s
instructions. The purity of the two subsets of cells was greater than
95% as determined using anti-CD14 or anti-CD15 mAbs.
Monocyte Activation
Freshly isolated monocytes (16106) were cultured in complete
RPMI medium containing 2 mM L-glutamine, 25 mM HEPES,
100 U/ml penicillin, 100 mg/ml streptomycin and 10% human
serum of blood group AB (Sigma) in the absence or presence of
2.5 mg/ml of the recombinant proteins rD-7, r6–8 or rD-7/D, or
with 2 mg/ml of LPS in 24-well plates. After 24 h, cells were
harvested and analysed by flow cytometry and culture superna-
tants were collected and stored at 280uC for cytokine detection.
To block the binding of rD-7 to CEACAM1 in some experiments,
monocytes were treated with A0115 or IgG control (50 mg/ml) for
1 h prior to the addition of the recombinant molecules as above.
After 24 h, cells were collected and surface staining conducted as
described below.
Flow Cytometry
Monocytes were harvested, washed with phosphate buffered
saline (PBS), and resuspended in FACS buffer (2% human serum,
0.5 mM EDTA in PBS). After staining with the fixable vital dye
eFluor 780, the cells were treated with FcR blocking buffer
containing 5% human serum for 15 min at 4uC. For detection of
surface receptors, cells were then treated with PE-conjugated
antibodies against CD86 or CD206; FITC-conjugated anti-CD14;
PE-Cy7 conjugated CD80; rabbit anti-CEACAM Ab A0115 and
PE-conjugated anti-rabbit IgG or PE-conjugated anti-CEACAM1
mAb (R and D Systems MAb2244). After 30 min incubation at
4uC, the cells were washed with 1 ml FACS buffer and fixed in
200 ml 1% paraformaldehyde in PBS.
For detection of surface-bound rD-7 or rD-7/D and their
inhibition by anti-CEACAM antibody, 16106 freshly isolated
monocytes or CD15+ cells were first incubated in the presence of
A0115 (50 mg/ml) or its IgG control (50 mg/ml) for 30 min on ice
and then with the recombinant bacterial molecules (2.5 mg/ml) for
1 h on ice. After treatment, cells were incubated with the vital dye
and blocking buffer as above before the addition of mouse anti rD-
7 antiserum [29], followed by PE-conjugated anti mouse IgG and
FITC-conjugated anti CD14 for gating monocytes and FITC-
conjugated anti CD15 Abs for gating CD15+ cells. Cells were
washed, fixed in 200ml 1% paraformaldehyde in PBS and analysed
by flow cytometry.
Luminex Assays
IL-6, IL-10, IL-12p70 and TNF-a in supernatants from
monocytes stimulated with rD-7 (2.5 mg/ml), rD-7/D (2.5 mg/
ml), or LPS (2 mg/ml) from four donors were quantitatively
measured by using MILLIPLEX MAP Human Cytokine/
Chemokine Magnetic Bead Panel I, Immunology Multiplex Assay
according to the manufacturer’s instructions (Millipore, MA,
USA). Data were analysed using the MAGPIX system (Millipore,
MA, USA).
Proteome Profiler Array
Monocytes from three donors were used for further analysis.
The Proteome Profiler human cytokine array Panel A kit was used
to measure the relative levels of cytokines and chemokines in cell
culture supernatants after stimulation with the recombinant
UspA1-derived molecules or LPS as above. The assays were
performed in duplicate according to the manufacturer’s instruc-
tions (R&D Systems, UK) using 1 ml of each supernatant.
Densities of dot blots were analysed using Odyssey Imaging
System (LI-COR, Nebraska, USA).
Statistical Analysis
Each experiment was performed on at least three separate
occasions and the number of independent experiments carried out
are stated in figure legends together with the number of replicates
for each data point. Statistical analyses were performed using
SPSS version 11.5. Normality of the data were tested using the
Shapiro-Wilk test. Data were normally distributed, and the results
are presented as the mean 6 standard deviation (SD). A one-way
analysis of variance (ANOVA) test was used for statistical
comparisons between groups (where number of groups $3) and
Dunnett test or Tukey test were used for post hoc analysis of the
significant ANOVA results. P,0.05 was considered statistically
significant.
Results
Modulation of Monocyte Differentiation by M. catarrhalis
UspA1-derived Recombinant Fragment rD-7
In order to investigate the effect of M. catarrhalis CEACAM-
binding surface adhesin UspA1 on monocyte differentiation and
function, monocytes were incubated with the CEACAM-binding
recombinant molecule rD-7 or a control molecule, r6–8,
corresponding to a region of UspA1 not involved in CEACAM
binding. After 24 h, their effects on CD206 (the alternative
activation marker of M2 macrophages), CD80 and CD86
expression were analysed using flow cytometry. The mean
fluorescence intensity (MFI) of CD14+ cells expressing CD206
was significantly increased by rD-7 compared with untreated or
r6–8-treated cells (Fig. 1). LPS also increased the MFI of CD14+
cells expressing CD206 but to a lesser extent than rD-7.
Additionally, while LPS increased CD80 expression, rD-7
decreased its expression; in contrast r6–8 did not affect CD80
expression. Neither rD-7 nor r6–8 affected the expression of CD86
by monocytes.
The Increased MFI of CD14+ Cells Expressing CD206
Modulated by rD-7 was Dependent on the Intact Protein
As LPS also increased the MFI of CD14+ cells expressing
CD206 after 24 h stimulation (Fig. 1A), we carried out further
experiments to ascertain whether residual levels of endotoxin in
the protein preparations were responsible for the observed effects.
Samples of rD-7 were digested with Proteinase K and added to
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monocyte differentiation cultures. The purity and proteolytic
digestion of rD-7 was confirmed by SDS-PAGE (Fig. S2). As
shown in Fig. 2A, CD206 expression was increased by rD-7, whilst
PK-treated rD-7 preparations lost the ability to increase CD206
expression by monocytes (Fig. 2B). These data indicate that
CD206 modulation was mediated by the protein fraction within
the rD-7 preparations.
CD14+ Monocytes Express CEACAM1, the Receptor of rD-
7
In order to determine whether the rD-7-induced modulation of
CD206 expression by monocytes was CEACAM-dependent, we
first determined the expression of CEACAM1 on monocytes by
flow cytometry using the polyclonal antibody A0115 as well as an
anti-CEACAM1 mAb (R and D Systems MAb2244) [40]. As
reported previously by Yu et al [24], low numbers of monocytes
expressing CEACAM1 were detected by both antibodies (Fig. 3).
rD-7-induced CD206 Expression on Monocytes is
Independent of the Ability to Bind CEACAM1
In further experiments, to assess the role of CEACAM-1 in rD-
7-induced CD206 expression, we used rD-7 as well as an rD-7
mutant with attenuated CEACAM binding (rD-7/D) [35]. When
monocytes were stimulated with either rD-7 or rD-7/D for 24 h,
CD206 expression was upregulated to similar levels in each case.
No such upregulation was found using protease-treated rD-7 and
rD-7/D. As observed previously, control stimulation with LPS
alone also increased CD206 expression which was not altered by
PK digestion (Fig. 4A and B).
For comparison, the binding of rD-7 and rD-7/D to CD15+
cells known to express high levels of CEACAMs [41] was also
determined by flow cytometry. In contrast to monocytes, while rD-
7 bound to CD15+ cells, rD-7/D did not bind to these cells
(Fig. 4C). The specificity of rD-7 binding to CEACAMs on
CD15+ cells was also determined by the use of A0115, known to
Figure 1. CD206, CD80 and CD86 expression on CD14+ cells after stimulation with rD-7 and r6–8. (A) 16106 monocytes were treated
with rD-7 (2.5 mg/ml), r6–8 (2.5 mg/ml) or LPS (2 mg/ml) for 24 h, cells collected and live cells sorted using the vital dye eFluor 780. CD14+ cells were
then gated for the analysis of CD206, CD80 and CD86 expression by flow cytometry. Black and grey histograms represent stained cells and unstained
cells respectively. (B) The MFI of CD14+ cells expressing CD206, CD80 or CD86 are shown. rD-7, r6–8 or LPS was used in three independent
experiments at least and each dot represents a separate experiment (*, P,0.05; ***, P,0.001).
doi:10.1371/journal.pone.0090999.g001
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block CEACAM binding by the recombinant molecule [28].
A0115 but not control IgG diminished the binding of rD-7
confirming the specificity of CEACAM binding by rD-7 on
CD15+ cells (Fig. 4C).
Confirmation of CEACAM-independent Binding and
Stimulation of CD206 Expression on CD14+ Cells by rD-7
and rD-7/D by Antibody Inhibition Assays
As rD-7 binding to CD15+ cells could be readily inhibited by
A0115, this antibody was used to first assess its effect on binding of
the recombinant molecule to CD14+ cells by flow cytometry.
While rD-7 (and rD-7/D also tested in parallel) bound to the
surface of monocytes, A0115 did not block the binding as observed
with IgG control (Fig. 5A). This was in contrast to results observed
with rD-7 binding to CD15+ cells (Fig. 4C).
Together, the above data suggested strongly that rD-7 may
modulate monocyte differentiation in a CEACAM-independent
manner. This was further confirmed by treating freshly isolated
monocytes with A0115 before stimulation with rD-7 or rD-7/D
for 24 h. Both rD-7 and rD-7/D enhanced CD206 expression and
this remained unaffected in the presence of A0115 (Fig. 5B) again
indicating that monocyte differentiation modulated by either rD-7
or rD-7/D was not dependent on their interaction with
CEACAMs.
IL-6, TNF-a, IL-10 and IL-12p70 Secretion from Monocytes
Stimulated by rD-7 and rD-7/D
One important function of monocytes and macrophages is to
produce pro-inflammatory and anti-inflammatory cytokines, such
as IL-12, TNF-a, IL-6 and IL-10, which may shape the nature of
the adaptive immune response. Therefore, IL-10, IL-12p70, IL-6
and TNF-a were quantified by Luminex assays, using monocyte
supernatants from four donors (Fig. 6). The results confirmed that
rD-7 and rD-7/D did not increase the secretion of IL-10 or IL-
12p70, whilst neither rD-7 nor rD-7/D induced IL-6 and TNF-a
secretion compared with the unstimulated group from the four
donors.
Cytokines and Chemokine Expression Profiles from
Monocytes Modulated by rD-7 or rD-7/D
As above assays using several donors gave similar results for rD-
7 and rD-7/D (similar effects on the expression of CD206, CD80,
CD86 and on the secretion of IL-10, IL-12p70, IL-6, TNF-a),
three representative supernatants from the four donors used in
Luminex assays were further used to determine the broader
cytokine and chemokine expression profiles as assessed by
proteome profiler assay. We observed a significant increase in
IL-1ra secretion produced by monocytes stimulated with rD-7 or
rD-7/D for 24 h. Interestingly, the quantity of IL-1ra released
following treatment with rD-7 or rD-7/D was similar to that from
the LPS-stimulated group (Fig. 7). In addition, IL-8 secretion was
also increased by either rD-7 or rD-7/D when compared to the
Figure 2. CD206 expression on CD14+ cells after stimulation with digested rD-7. (A) Monocytes were treated with rD-7 (2.5 mg/ml), or PK-
digested rD-7 for 24 h and CD206 expression on CD14+ cells was analysed as described in legend to Fig. 1. Black and grey histograms represent
stained cells and unstained cells respectively. (B) The MFI of CD14+ cells expressing CD206 are shown.rD-7 or digested rD-7 was used in three
independent experiments at least and each dot represents a separate experiment (***, P,0.001).
doi:10.1371/journal.pone.0090999.g002
UspA1 Induces CD14+CD206+ Monocyte Differentiation
PLOS ONE | www.plosone.org 5 March 2014 | Volume 9 | Issue 3 | e90999
unstimulated group (Fig. 7). IL-2, IL-4, IL-5, IL-10, IL-12p70, IL-
17, IL-32a, MCP-1, MIP-1b, CXCL10 and CXCL12 were
undetectable in rD-7- or rD-7/D-stimulated groups (Mean pixel
density was less than 0.1). There was no significant change for
C5a, CD40 ligand, G-CSF, GM-CSF, CXCL1, CCL1, sICAM-1,
IFN-c, IL-1a, IL-1b, IL-6, IL-13, IL-16, IL-17E, IL-23, IL-27,
CXCL11, MIF, CCL3, Serpin E1, CCL5, TNF-a, sTREM-1
secretion between the rD-7 or rD-7/D groups and the
unstimulated group (Fig. 7).
Discussion
During the microbial infection process, circulating blood
monocytes migrate from the vasculature into the extra-vascular
compartment where they mature into tissue macrophages [42]. In
1992, Stahl reported that the mannose receptor CD206 was not
found on circulating monocytes, while it was abundantly expressed
on differentiated macrophages [43] and the LPS-induced differ-
entiation of monocytes to macrophages involved NFkB [42]. In
our studies, we also observed that the expression of CD206 on
unstimulated CD14+ monocytes was low but its expression on
CD14+ cells treated with rD-7 for 24 h was significantly increased,
suggesting rD-7 initiates monocyte differentiation into macro-
phages. In terms of classically activated M1 macrophages and
alternatively activated M2 macrophages, it has been shown that
monocytes/macrophages co-cultured with Tregs display typical
features of alternative activated macrophages, including up-
regulated expression of CD206 and CD163, an increased
production of CCL18, and an enhanced phagocytic capacity
[44]. Enhanced CD206 may be involved in phagocytosis, antigen
processing and presentation, cell migration and intracellular
signalling [45,46].
CD80 is expressed on antigen-presenting cells. It provides a co-
stimulatory signal necessary for T cell activation and survival, and
is the ligand for CD28 and CTLA-4 (CD152) [47,48], which have
crucial yet opposing functions in T-cell stimulation. CD80 works
in tandem with CD86 in priming T cells and it is also considered a
marker of DC and macrophage maturation [49,50]. Notably, we
found that CD80 expression on CD14+ cells was significantly
decreased by rD-7 after 24 h stimulation, suggesting that despite
driving differentiation, rD-7 may impair the acquisition of full
APC function. This property of rD-7 was in marked contrast to the
effects of LPS, which increased CD80 expression on CD14+ cells.
Similarly, rD-7 did not alter CD86 expression on CD14+ cells in
our experiments, whereas as is consistent with other reports, LPS
induced early upregulation of CD86, but then levels declined such
that by 24 h, levels of CD86 expression on LPS-treated monocytes
were lower than on untreated controls [51]. These data suggest
that the effects of LPS and rD-7 on monocyte differentiation were
Figure 3. Analyses of CEACAM1 expression on CD14+ monocytes. (A) Monocytes were incubated with rabbit anti-CEACAM antibody A0115
(black histogram) or its IgG control (grey histogram) followed by secondary PE-conjugated anti-rabbit IgG and FITC-conjugated CD14 mAb. Dotted
histogram represents secondary antibody only control. (B) Cells were also labelled with PE-conjugated anti-CEACAM1 mAb (R and D Systems
MAb2244) (black histogram) or its isotype control (grey histogram) and FITC-conjugated CD14 mAb. Live CD14+ cells were analysed and the
percentages of cells expressing CEACAM1 were found to be 7.265.1% using A0115 and 13.964.1% using MAb2244. The MFI plots of CEACAMs on
CD14+ monocytes are shown on the right (*, P,0.05; **, P,0.01).The three dots in each case represent data from monocytes obtained from three
donors. Note the differences in the values shown for the two antibodies could also be assigned to the experiments being performed using two
different instruments (Canto II, University of Bristol and Calibur, Shandong University respectively) using different settings.
doi:10.1371/journal.pone.0090999.g003
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different, and may point towards modulation of the differentiation
pathway away from a fully activated phenotype.
It has been reported that the UspA1 protein of M. catarrhalis
induces CEACAM1-dependent apoptosis in alveolar epithelial
cells and that this might contribute to the pathogenesis of chronic
obstructive pulmonary disease (COPD) [30]. Besides, the UspA1
protein may also modulate the function of other cells expressing
CEACAM1, including migrated CEACAM1 expressing mono-
cytes and activated T cells at inflammatory sites. Using primers
based on the UspA1 gene sequence of M. catarrhalis, recombinant
polypeptides of different length were generated. rD-7 represents
residues 527–677, and rD-7/D represents residues 527–677 but
with two mutations, M568A and A588Q, whilst r6–8 represents
residues 659–863 [34]. We observed that monocyte differentiation
was modulated by rD-7 and rD-7/D but not r6–8, implying the
receptor target responsible for monocyte differentiation by rD-7
and rD-7/D was contained within residues 527–677 of UspA1.
We have determined the cytokine secretion profiles after
stimulation with rD-7. There were marked differences in the
profiles of cytokines induced in response to rD-7 when compared
to LPS. rD-7 appeared to induce a response involving primarily
IL-1ra, an inhibitor of the pro-inflammatory effects of IL-1a and
IL-1b [52], along with low levels of pro-inflammatory factors,
TNF-a, IL-1b and IL-6. In contrast, LPS induced far higher levels
Figure 4. CD206 expression on CD14+ cells after stimulation with rD-7/D. (A) Monocytes treated with rD-7, rD-7/D, or PK-digested samples
of the proteins (2.5 mg/ml each) were collected after 24 h, live CD14+ cells were gated and CD206 expression was analysed. Black and grey
histograms represent stained and unstained cells respectively. (B) The MFI of CD14+ cells expressing CD206 are shown. rD-7, rD-7/D, LPS, digested rD-
7, digested rD-7/D or Proteinase k was used in three independent experiments at least and each dot represents a separate experiment. (C) Surface
binding of rD-7 to CD15+ cells. 16106 CD15+ cells were blocked with A0115 or its IgG control (50 mg/ml) for 30 min on ice, the cells were then
stimulated with rD-7 or rD-7/D (2.5 mg/ml each) for 1 h on ice, rD-7 bound to live CD15+ cells was detected with primary mouse anti rD-7 antiserum
and secondary PE-conjugated anti mouse IgG Abs by flow cytometry. (*, P,0. 05; **, P,0. 01; ***, P,0. 001).
doi:10.1371/journal.pone.0090999.g004
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of pro-inflammatory TNF-a, IL-1b and IL-6. Interleukin-8 was
produced at high levels by the cells in the absence of stimulation,
levels increasing to a small extent further following rD-7 exposure.
The rD-7 and LPS induced cytokine profiles were consistent in
both assays used to assess their production and suggest that rD-7
modulates monocyte activation in a way that is distinct from LPS.
Despite the continued presence of IL-8 production, the overall
profile induced by rD-7 in which IL-1ra is stimulated in the
relative absence of pro-inflammatory IL-1b, TNF-a and IL-6 is
Figure 5. Ab A0115 does not affect binding of rD-7 or CD206 expression on CD14+ cells. (A) Monocytes were pre-treated with A0115 or
its IgG control (50 mg/ml each) for 30 min on ice and then rD-7 (2.5 mg/ml) or rD-7/D (2.5 mg/ml) added for 1 h. The surface bound of rD-7 on live
CD14+ cells was detected with primary mouse anti rD-7 antiserum and secondary PE-conjugated anti mouse IgG Abs and FITC-conjugated anti CD14
mAb. (B) Monocytes were treated with A0115 or its IgG control (50 mg/ml) for 1 h and the cells were then stimulated with rD-7 or rD-7/D (2.5 mg/ml
each) for 23 h. CD206 expression was analysed on live CD14+ cells. Black and grey histograms represent stained cells and unstained cells. (C) The MFI
of CD14+ cells expressing CD206 are shown. Experiments were conducted three and four times as shown. Each dot represents an independent
experiment. (*, P,0. 05; **, P,0. 01; ***, P,0. 001).
doi:10.1371/journal.pone.0090999.g005
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suggestive that the protein may regulate rather than overtly drive
inflammation.
CEACAM1 is expressed on several types of cell, serving as a
sophisticated and multi-potent signalling molecule which partic-
ipates in regulating a variety of important cellular activities.
Human monoblast cell lines U-937 and THP-1 have been shown
to express CEACAM1 at the gene and protein level [53], and
CEACAM1 was found to be expressed by primary CD14+
monocytes, albeit to a lower level than lymphocytes [24]. We also
found CEACAM expression to be low on CD14+ monocytes using
anti-CEACAM antibodies. According to the type and number of
amino acid residues in the cytoplasmic domain, CEACAM1 is
classified into CEACAM1-Long (73 amino acids) and CEA-
CAM1-Short isoforms (10 amino acids). The CEACAM1-L
contains two intracellular ITIMs like motifs not present in
CEACAM1-S [54]. Activation of CEACAM1-L leads to the
recruitment of Src homology 2 domain containing protein tyrosine
phosphatase-1 (SHP-1) and SHP-2 to phosphorylated ITIM
[55,56], which initiates a number of signalling pathways. RT-
PCR has been performed to ascertain that CEACAM1-3L (3
extracellular domains, 207 bp product) and CEACAM1-4L (4
extracellular domains, 506 bp product) were co-expressed by
primary human monocytes [24]. We aimed to investigate whether
the differentiation induced by rD-7 was mediated in a CEA-
CAM1-dependent manner. For this reason, a control protein rD-
7/D that displayed greatly reduced binding to CEACAM1 was
used for stimulation. Unexpectedly, rD-7/D also increased CD206
expression on monocytes and there was no significant difference
between CD206 expression and cytokine secretion in the rD-7 and
rD-7/D treated cells, suggesting that the effects of rD-7 on
monocytes differentiation were not mediated in a CEACAM-
dependent manner. To test this hypothesis, we used the antibody
A0115 to block the binding of rD-7 to CEACAMs [28]. The
antibody neither affected the surface binding of rD-7 or rD-7/D
nor blocked the increase in CD206 expression. In addition, using
CD15+ neutrophils expressing high levels of CEACAM1, we
found little binding of rD-7/D while rD-7 bound to the cells in a
CEACAM-dependent manner which was inhibited by A0115.
Although our data suggest that there is predominantly a
CEACAM-independent mechanism for rD-7 binding to mono-
cytes, it is also feasible that it may bind to a lesser extent in a
CEACAM-dependent manner. However, only a small number of
monocytes (,5%) have been reported to express CEACAMs [24]
in contrast to CD15+ neutrophils (,100%) [41]. The monocyte
receptor/s targeted by the region of M. catarrhalis UspA1
represented specifically in rD-7 and rD-7/D remain unknown
and require further investigation.
In summary, our studies have shown that M. catarrhalis UspA1-
derived recombinant molecules rD-7 and rD-7/D induced
monocytes differentiation into a CD14+CD206+ phenotype.
The expression of CD80 was significantly decreased by rD-7,
and high levels of IL-1ra secretion was induced. Taken together
with the observation that of the pro-inflammatory cytokines tested,
IL-8 was the only one where levels remained high after rD-7
Figure 6. TNF-a, IL-6, IL-10 and IL-12p70 from monocytes modulated by rD-7 or rD-7/D. Supernatants of 16106 monocytes stimulated
with rD-7 (2.5 mg/ml), rD-7/D (2.5 mg/ml) or LPS (2 mg/ml) for 24 h were collected and TNF-a (A), IL-6 (B), IL-10 (C) and IL-12p70 (D) secretion was
determined by using Luminex assay kit. Each dot represents the mean of triplicate estimations within an experiment and the four dots in each case
represent data from monocytes obtained from four donors (*, P,0.05; **, P,0.01, ***, P,0.001).
doi:10.1371/journal.pone.0090999.g006
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treatment, our findings suggest that it may regulate rather than
induce inflammation. Both rD-7 and rD7/D bound to and
modulated monocyte function in a CEACAM1-independent
manner. The nature of this receptor has yet to be elucidated
and remains an exciting target for future research. Further
understanding of the mechanisms via which M. catarrhalis may
modulate monocyte function via its surface-expressed virulence
determinants such as UspA1 will add to our knowledge and better
inform future vaccine design.
Supporting Information
Figure S1 Purity of rD-7 and rD-7/D and their binding
to soluble CEACAM1 construct. Purified recombinant
molecules were analysed by SDS-PAGE and western blotting.
The bands of the expected size (17 kDa) were observed in
Coomassie Blue stained gels (left) and in Western blots detected
with anti-His tag antibody (middle) and CEACAM1-Fc construct
described previously [39]. The 17 kDa band in the rD-7 and rD-
7/D were detected with anti-His tag antibody followed by anti-
mouse IgG secondary antibody conjugated to alkaline phospha-
tase. CEACAM1-Fc bound to rD-7 but not rD-7/D. Receptor
binding was detected using an anti-human-Fc antibody conjugated
to alkaline phosphatase. In the case of both anti-His tag and
receptor overlay, alkaline phosphatase conjugates binding was
detected by the addition of nitroblue tetrazolium and 5-bromo-4-
chloro-3-indoyl phosphate as substrates.
(TIF)
Figure S2 Proteinase K treatment of rD-7 and rD-7/D.
Purified samples of rD-7, rD-7/D, or LPS were digested by
200 mg/ml Proteinase K at 37uC for 3 h. The digested samples
were heat-inactivated at 95uC for 1 h to inactive Proteinase K and
analysed by SDS-PAGE. Sample 1, rD-7; Sample 2, Digested rD-
Figure 7. Cytokine and chemokine expression profiles from monocytes modulated by rD-7. Supernatants of monocytes stimulated with
rD-7 or rD-7/D from three donors were used to assess their cytokine and chemokine expression using Proteome Profiler R&D Systems according to
the manufacturer’s instructions. The experiments were performed in duplicate using monocytes from three of the four donor samples shown in Fig.
6. Results of one of three donor samples are shown in A and the rest are shown in Fig. S3 (*, P,0.05; **, P,0.01, ***, P,0.001). The mean pixel density
of dots shown in B were obtained using Odyssey Imaging System using data from all three donors.
doi:10.1371/journal.pone.0090999.g007
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7; Sample 3, rD-7/D; Sample 4, Digested rD-7/D; Samples 5 and
6, Proteinase K; Sample 7, rD-7 with heat-inactivated Proteinase
K; Sample 8, rD-7/D with heat-inactivated Proteinase K.
(TIF)
Figure S3 Cytokine and chemokine expression profiles
from monocytes modulated by rD-7. Supernatants of
monocytes stimulated with rD-7 or rD-7/D from donor 2(A)
and donor 3 (B) were used to assess their cytokine and chemokine
expression using Proteome Profiler R&D Systems according to the
manufacturer’s instructions (data supplementary to Fig. 7).
(TIF)
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